drugset / Trial / NCT03530228

A Phase 1 Study of Tegoprazan on Healthy Male Volunteers

NCT03530228

Phase 1 Unknown 44 enrolled HK inno.N Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

A randomized, open-label, active-controlled, single/multiple-dose phase 1 clinical trial to evaluate pharmacokinetics/pharmacodynamics and safety/tolerability of tegoprazan after oral administration in healthy male subjects

Timeline

Start
2018-05
Primary completion
2018-08
Completion
2018-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esomeprazole Small molecule Oral
Subject Tegoprazan Other / unclassified Oral

Indications

No indication recorded.